Skip to content

Clinical trials

Phase 3 Colitis, Ulcerative trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colitis, Ulcerative Phase: Phase 3 Country / region: Australia Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20071
20081
20091
20124
20145
20155
20162
20172
20187
20192
20201
20213
20222
20234
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Active, not recruiting9
Recruiting5
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC7
Pfizer6
Takeda6
AbbVie4
Hoffmann-La Roche4
Shire4
Eli Lilly and Company3
Abivax S.A.2
Arena Pharmaceuticals2
Celgene2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative49
Inflammatory Bowel Diseases6
Crohn Disease5
Arthritis, Juvenile1
Arthritis, Psoriatic1
Gastroenteritis1
Gastrointestinal Diseases1

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.